Showing results (2281-2290 of 6,891) with videos related to

Sort By:
Pageof 690
Stroke Research and Treatment|July 27, 2011
Infection after acute ischemic stroke: risk factors, biomarkers, and outcomeKatja E Wartenberg, Anett Stoll, Andreas Funk, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|December 15, 2011
Endogenous Candida albicans endophthalmitis following spontaneous abortion and IUD removalRishi R Doshi, Jon D Wender, J Michael Jumper, et al.
Psychology in the Schools|February 14, 2012
IDENTIFYING PSYCHOSOCIAL DYSFUNCTION IN SCHOOL-AGE CHILDREN: THE PEDIATRIC SYMPTOM CHECKLIST AS A SELF-REPORT MEASUREMaria E Pagano, Linden J Cassidy, Michelle Little, et al.
Plant Disease|September 14, 2020
Carpogenic Germinability of Diverse Sclerotinia sclerotiorum Populations Within the Southwestern Australian Grain BeltPippa J Michael, King Yin Lui, Linda L Thomson, et al.
Biophysical Journal|April 28, 2004
Monte Carlo simulations of locally melted supercoiled DNAs in 20 mM ionic strengthChristopher A Sucato, David P Rangel, Dan Aspleaf, et al.
Spine|June 2, 2005
Construction and validation of the scoliosis quality of life index in adolescent idiopathic scoliosisRonald J Feise, Sandra Donaldson, Edward R Crowther, et al.
Environmental Monitoring and Assessment|June 4, 2005
A method of mercury removal from topsoil using low-thermal applicationRafal Kucharski, Urszula Zielonka, Aleksandra Sas-Nowosielska, et al.
Peptides|May 12, 2005
Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivativesJ Michael Conlon, Bency Abraham, Sehamuddin Galadari, et al.
Advances in Experimental Medicine and Biology|February 9, 2013
High sugar intake blunts arterial baroreflex via estrogen receptors in perinatal taurine supplemented ratsAtcharaporn Thaeomor, J Michael Wyss, Stephen W Schaffer, et al.
Journal of the American Heart Association|January 15, 2013
Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjectsJ Michael Gaziano, Anthony H Cincotta, Aaron Vinik, et al.
Pageof 690